nach oben

Cancer Immunology, Immunotherapy

Erschienen in:

01.08.2004 | Opinion Paper

How should clinical data be included in experimental studies of cancer immunology?

verfasst von: Bjørn Tore Gjertsen, Øystein Bruserud

Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 8/2004

Einloggen, um Zugang zu erhalten

Abstract

Patients diagnosed with the same malignant disease are often heterogeneous with regard to age, complications, malignant cell morphology and tumor histology, disease stage, prognostic parameters, and previous therapy. Many of these factors can affect immunocompetent cells or influence the malignant cell susceptibility to immunotherapy. Summaries of relevant clinical information should therefore be included in cancer immunology studies to increase the present as well as the future scientific impact. Guidelines for selection of relevant information are suggested in the article.

Barber MD, Ross JA, Fearon KC (1999) Cancer cachexia. Surg Oncol 8:133CrossRefPubMed

Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G, Yulug I, Merlano M, Numico G, Comino A, Attard M, Reelfs O, Gusterson B, Bell AK, Heath V, Tavassoli M, Farrell PJ, Smith P, Lu X, Crook T (2003) p53 Polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell 3:387PubMed

Bladergroen BA, Meijer CJ, ten Berge RL, Hack CE, Muris JJ, Dukers DF, Chott A, Kazama Y, Oudejans JJ, van Berkum O, Kummer JA (2002) Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system? Blood 99:232CrossRefPubMed

Bruserud Ø, Hovland R, Wergeland L, Huang T-S, Gjertsen BT (2003) Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of the effects of Flt3-ligand in AML cell populations with and without Flt3 abnormalities. Haematologica 88:416PubMed

Clark PE, Irvine RA, Coetzee GA (2003) The androgen receptor CAG repeat and prostate cancer risk. Methods Mol Med 81:255CrossRefPubMed

Crocker IP, Lawson N, Baker PN, Fletcher J (2001) The anti-inflammatory effects of circulating fatty acids in obstructive jaundice: similarities with pregnancy-induced immunosuppression. QJM 94:475

Dreger P, Viehmann K, von Neuhoff N, Glaubitz T, Petzoldt O, Glass B, Uharek L, Rautenberg P, Suttorp M, Mills B, Mitsky P, Schmitz N (1999) Autografting of highly purified blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery. Bone Marrow Transplant 24:153CrossRefPubMed

Kalil N, Cheson BD (1999) Chronic lymphocytic leukemia. Oncologist 4:352PubMed

Lazarus R, Vercelli D, Palmer LJ, Klimecki WJ, Silverman EK, Richter B, Riva A, Ramoni M, Martinez FD, Weiss ST, Kwiatkowski DJ (2002) Single nucleotide polymorphisms in innate immunity genes: abundant variation and potential role in complex human disease. Immunol Rev 190:9.CrossRefPubMed

10.

Lieubeau B, Heymann MF, Henry F, Barbieux I, Meflah K, Gregoire M (1999) Immunomodulatory effects of tumor-associated fibroblasts in colorectal-tumor development. Int J Cancer 81:629CrossRefPubMed

11.

Lillie EO, Bernstein L, Ursin G (2003) The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer. Breast Cancer Res 5:164CrossRefPubMed

12.

Mackall CL, Fleisher TA, Brown MR, Magrath IT, Shad AT, Horowitz ME, Wexler LH, Adde MA, McClure LL, Gress RE (1994) Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 84:2221PubMed

13.

Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Horowitz ME, Magrath IT, Shad AT, Steinberg SM. (1995) Age, thymopoiesis, and CD4⁺ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 332:143CrossRefPubMed

14.

Mackall CL, Fleischer TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Magrath IT, Wexler LH, Dimitrov DS, Gress RE (1997) Distinctions between CD8⁺ and CD4⁺ T cell regenerative pathways result in prolonged T cell subset imbalance after intensive chemotherapy. Blood 89:3700.PubMed

15.

Mackall CL, Stein D, Fleisher TA, Brown MR, Hakim FT, Bare CV, Leitman SF, Read EJ, Carter CS, Wexler LH, Gress RE (2000) Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults. Blood 96:754PubMed

16.

McCarthy LC, Davies KJ, Campbell DA (2002) Pharmacogenetics in diverse ethnic populations--implications for drug discovery and development. Pharmacogenomics 3:493PubMed

17.

Molloy EJ, O’Neill AJ, Grantham JJ, Sheridan-Pereira M, Fitzpatrick JM, Webb DW, Watson RW (2003) Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone. Blood 102:2653CrossRefPubMed

18.

Oppenheimer SJ (2001) Iron and its relation to immunity and infectious diseases. J Nutr 131:616SPubMed

19.

Pawelec G, Barnett Y, Forsey R, Frasca D, Globerson A, McLeod J, Caruso C, Franceschi C, Fulop T, Gupta S, Mariani E, Mocchegiani E, Solana R (2002) T cells and aging, January 2002 update. Front Biosci 7:1056PubMed

20.

Pedersen BK, Toft AD (2000) Effects of exercise on lymphocytes and cytokines. Br J Sports Med 34:246CrossRefPubMed

21.

Schroder J, Kahlke V, Staubach KH, Zabel P, Stuber F (1998) Gender differences in human sepsis. Arch Surg 133:1200PubMed

22.

Shresta S, Pham CT, Thomas DA, Graubert TA, Ley TJ (1998) How do cytotoxic lymphocytes kill their targets? Curr Opin Immunol 10:581PubMed

23.

Talmadge JE, Reed EC, Kessinger A, Kuszynski CA, Perry GA, Gordy CL, Mills KC, Thomas ML, Pirruccello SJ, Letheby BA, Arneson MA, Jackson JD (1996) Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation. Bone Marrow Transplant 17:101PubMed

24.

Talmadge JE, Reed E, Ino K, Kessinger A, Kuszynski C, Heimann D, Varney M, Jackson J, Vose JM, Bierman PJ (1997) Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 19:161PubMed

25.

Ungefroren H, Kruse ML, Trauzold A, Roeschmann S, Roeder C, Arlt A, Henne-Bruns D, Kalthoff H (2001) FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis. J Cell Sci 114:2735PubMed

26.

Vos M, Adams CH, Victor TC, van Helden PD (2003) Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa. Cancer Genet Cytogenet 140:23CrossRefPubMed

27.

Wendelbo Ø, Nesthus I, Sjo M, Ernst P, Bruserud Ø (2004) Cellular immune responses in multiple myeloma patients with treatment-induced cytopenia early after high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Leukemia Res (in press)

28.

Wendelbo Ø, Nesthus I, Sjo M, Paulsen K, Ernst P, Bruserud Ø (2004) Functional characterization of T Lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia. Cancer Immunol Immunother 53 (DOI 10.1007/s00262-004-0505-0)

Titel: How should clinical data be included in experimental studies of cancer immunology?
verfasst von: Bjørn Tore Gjertsen
Øystein Bruserud
Publikationsdatum: 01.08.2004
Verlag: Springer-Verlag
Erschienen in: Cancer Immunology, Immunotherapy / Ausgabe 8/2004
Print ISSN: 0340-7004
Elektronische ISSN: 1432-0851
DOI: https://doi.org/10.1007/s00262-004-0515-y

Neu im Fachgebiet Onkologie

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

How should clinical data be included in experimental studies of cancer immunology?

Abstract

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2004

Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates

Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma

Antitumor effects of fusions composed of dendritic cells and fibroblasts transfected with genomic DNA from tumor cells

An epigenetically altered tumor cell vaccine

Immunotherapy of cancer for the elderly patient: does allogeneic bone marrow transplantation after nonmyeloablative conditioning provide a new option?

Strategies for immune therapy: Würzburg, Germany, 29 February–3 March 2004

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Update Onkologie